Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 24:2013:726912.
doi: 10.1155/2013/726912. eCollection 2013.

Arteriovenous passage times and visual field progression in normal tension glaucoma

Affiliations

Arteriovenous passage times and visual field progression in normal tension glaucoma

Eva Charlotte Koch et al. ScientificWorldJournal. .

Abstract

Purpose: Fluorescein angiographic studies revealed prolonged arteriovenous passage (AVP) times and increased fluorescein filling defects in normal tension glaucoma (NTG) compared to healthy controls. The purpose of this study was to correlate baseline AVP and fluorescein filling defects with visual field progression in patients with NTG.

Patients and methods: Patients with a follow-up period of at least 3 years and at least 4 visual field examinations were included in this retrospective study. Fluorescein angiography was performed at baseline using a confocal scanning laser ophthalmoscope (SLO, Rodenstock Instr.); fluorescein filling defects and AVP were measured by digital image analysis and dye dilution curves (25 Hz). Visual field progression was evaluated using regression analysis of the MD (Humphrey-Zeiss, SITA-24-2, MD progression per year (dB/year)). 72 patients with NTG were included, 44 patients in study 1 (fluorescein filling defects) and 28 patients in study 2 (AVP).

Results: In study 1 (mean follow-up 6.6 ± 1.9 years, 10 ± 5 visual field tests), MD progression per year (-0.51 ± 0.59 dB/year) was significantly correlated to the age (P = 0.04, r = -0.29) but not to fluorescein filling defects, IOP, or MD at baseline. In study 2 (mean follow-up 6.6 ± 2.2 years, 10 ± 5 visual field tests), MD progression per year (-0.45 ± 0.51 dB/year) was significantly correlated to AVP (P = 0.03, r = 0.39) but not to age, IOP, or MD at baseline.

Conclusion: Longer AVP times at baseline are correlated to visual field progression in NTG. Impaired retinal blood flow seems to be an important factor for glaucoma progression.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Bivariate plot of fluorescein filling defects (P = 0.37, r = −0.14) as a function of MD progression per year in patients with NTG.
Figure 2
Figure 2
Bivariate plot of AVP (P = 0.03, r = −0.39) as a function of MD progression per year in patients with NTG.

Similar articles

Cited by

References

    1. Boland MV, Quigley HA. Risk factors and open-angle glaucoma: classification and application. Journal of Glaucoma. 2007;16(4):406–418. - PubMed
    1. Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Survey of Ophthalmology. 2008;53(6):3–10. - PubMed
    1. Friedman DS, Wilson MR, Liebmann JM, Fechtner RD, Weinreb RN. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. American Journal of Ophthalmology. 2004;138(3):19–31. - PubMed
    1. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Archives of Ophthalmology. 2003;121(1):48–56. - PubMed
    1. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention study. Ophthalmology. 2004;111(9):1627–1635. - PubMed

LinkOut - more resources